Study S000048

Comparison of Efficacy of Liraglutide, Metformin and Gliclazide MR on Hepatic Lipid Content in Patients With Type 2 Diabetes (T2DM) and Non-alcoholic Fatty Liver (NAFLD)

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT03068065
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 87
Start: 2014-05
Primary completion: 2014-11
Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions: Non-Alcoholic Fatty Liver Disease; Type2 Diabetes
Interventions: DRUG:Liraglutide; DRUG:Metformin; DRUG:Gliclazide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Intrahepatic fat [-7±3days; 168±3days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.